Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update

Company continues to advance launch, reports initial revenue from Omisirge^® (omidubicel-onlv)

Company to host conference call today at 8:30 a.m. ET

Read more at globenewswire.com